Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies

Shu Fang; Nan Wang; Lili Wang; Jishan Du; Jingjing Yang; Yanan Wen; Yan Wei; Kun Qian; Hao Wang; Yifan Jiao; Chunji Gao; Liping Dou

doi:10.12659/AOT.937356

11 October 2022: Original Paper

Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies

Shu Fang ^12ABCDEF* , Nan Wang ^23ABCF* , Lili Wang ^2ABCD* , Jishan Du ^23BCF , Jingjing Yang ^23BCF , Yanan Wen ^23BCF , Yan Wei ^23BCF , Kun Qian ^12BCD , Hao Wang ^23ABF , Yifan Jiao ^23BCF , Chunji Gao ^12ACEG* , Liping Dou ^2ABDEG*

DOI: 10.12659/AOT.937356

Ann Transplant 2022; 27:e937356

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 (A–E) Comparison of cumulative incidence of relapse, non-relapse mortality, OS, DFS, and GRFS (R version 4.0.3). OS – overall survival; DFS – disease-free survival; GRFS – GVHD-free relapse-free survival; GVHD – graft-versus-host disease.

Back to the Article

Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies

Your Privacy